Interleukin-17 Blockade Leads to Shifts from Stage-based Towards Response-based Disease Clusters- Comparative Data from Very Early and Established Psoriatic Arthritis

Kampylafka E, Tascilar K, Lerchen V, Linz C, Sokolova M, Zekovic A, Kleyer A, Simon D, Rech J, Sticherling M, Schett G, Hueber A (2020)

Publication Type: Conference contribution

Publication year: 2020

Journal

Arthritis and Rheumatology Wiley

Publisher: WILEY

City/Town: HOBOKEN

Conference Proceedings Title: ARTHRITIS & RHEUMATOLOGY

DOI: 10.21203/rs.3.rs-36002/v1

Authors with CRIS profile

Veronika Lerchen Lehrstuhl für Innere Medizin III Christina Linz Lehrstuhl für Innere Medizin III Arnd Kleyer Department of Medicine 3 – Rheumatology and Immunology David Simon Department of Medicine 3 – Rheumatology and Immunology Hans Jürgen Rech Department of Medicine 3 – Rheumatology and Immunology Michael Sticherling Professur für Dermatologie Georg Schett Lehrstuhl für Innere Medizin III Axel Hueber Department of Medicine 3 – Rheumatology and Immunology

How to cite

APA:

Kampylafka, E., Tascilar, K., Lerchen, V., Linz, C., Sokolova, M., Zekovic, A.,... Hueber, A. (2020). Interleukin-17 Blockade Leads to Shifts from Stage-based Towards Response-based Disease Clusters- Comparative Data from Very Early and Established Psoriatic Arthritis. In ARTHRITIS & RHEUMATOLOGY. HOBOKEN: WILEY.

MLA:

Kampylafka, Eleni, et al. "Interleukin-17 Blockade Leads to Shifts from Stage-based Towards Response-based Disease Clusters- Comparative Data from Very Early and Established Psoriatic Arthritis." Proceedings of the ARTHRITIS & RHEUMATOLOGY HOBOKEN: WILEY, 2020.

BibTeX: Download